Research progress on signaling pathways in cirrhotic portal hypertension

摘要

Portal hypertension(PHT)is an important consequence of liver cirrhosis,which can lead to complications that adversely affect a patient’s quality of life and survival,such as upper gastrointestinal bleeding,ascites,and portosystemic encephalopathy.In recent years,advances in molecular biology have led to major discoveries in the pathological processes of PHT,including the signaling pathways that may be involved:PI3K-AKT-mTOR,RhoA/Rho-kinase,JAK2/STAT3,and farnesoid X receptor.However,the pathogenesis of PHT is complex and there are numerous pathways involved.Therefore,the targeting of signaling pathways for medical management is lagging.This article summarizes the progress that has been made in understanding the signaling pathways in PHT,and provides ideas for treatment of the disorder.